D. A. Deny

Engineered Fn3 protein has targeted therapeutic effect on mesothelin‐expressing cancer cells and increases tumor cell sensitivity to chemotherapy

Yanxuan Li, Allison R. Sirois, Sarah J Moore, 2019, Biotechnology and bioengineering.

Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding

Allison R. Sirois, Sarah J Moore, D. A. Deny, 2018, PloS one.

Biotechnology and Bioengineering

J. Berlo, Allison R. Sirois, Daniel W. Sorensen, 2019 .